ANXA1 and rheumatoid arthritis: More importantly, silencing the expression of ANXA1 in RA FLS strongly inhibited the HA-degrading activity of membrane-bound sKIAA1199 (Fig. 4F) and resulted in a collective reduction of TNF-α, IL-1β, and IL-6 levels in the medium (Fig. 4G–I).